These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26965791)

  • 1. Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial.
    Xu L; Liu S; Guan M; Xue Y
    Med Sci Monit; 2016 Mar; 22():810-7. PubMed ID: 26965791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
    Schumacher HR; Boice JA; Daikh DI; Mukhopadhyay S; Malmstrom K; Ng J; Tate GA; Molina J
    BMJ; 2002 Jun; 324(7352):1488-92. PubMed ID: 12077033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial.
    Li T; Chen SL; Dai Q; Han XH; Li ZG; Wu DH; Zhang X; Gu JR; Yang NP; Sun LY; Zhang MJ; Li XF; Bao CD
    Chin Med J (Engl); 2013; 126(10):1867-71. PubMed ID: 23673101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
    Rubin BR; Burton R; Navarra S; Antigua J; Londoño J; Pryhuber KG; Lund M; Chen E; Najarian DK; Petruschke RA; Ozturk ZE; Geba GP
    Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
    Navarra S; Rubin BR; Yu Q; Smugar SS; Tershakovec AM
    Curr Med Res Opin; 2007 Jul; 23(7):1685-91. PubMed ID: 17588299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Huzhang Granule, a compound Chinese herbal medicine, for acute gouty arthritis: A double-blind, randomized controlled trial.
    Wang H; Chen ST; Ding XJ; Kuai L; Hua L; Li X; Wang YF; Zhang M; Li B; Wang RP; Zhou M
    J Integr Med; 2024 May; 22(3):270-278. PubMed ID: 38553375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
    Zhang S; Zhang Y; Liu P; Zhang W; Ma JL; Wang J
    Clin Rheumatol; 2016 Jan; 35(1):151-8. PubMed ID: 26099603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.
    Man CY; Cheung IT; Cameron PA; Rainer TH
    Ann Emerg Med; 2007 May; 49(5):670-7. PubMed ID: 17276548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.
    Terkeltaub RA; Schumacher HR; Carter JD; Baraf HS; Evans RR; Wang J; King-Davis S; Weinstein SP
    Arthritis Res Ther; 2013 Feb; 15(1):R25. PubMed ID: 23375025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
    Croom KF; Siddiqui MA
    Drugs; 2009 Jul; 69(11):1513-32. PubMed ID: 19634927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study.
    Zerbini C; Ozturk ZE; Grifka J; Maini M; Nilganuwong S; Morales R; Hupli M; Shivaprakash M; Giezek H;
    Curr Med Res Opin; 2005 Dec; 21(12):2037-49. PubMed ID: 16368055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoricoxib.
    Cochrane DJ; Jarvis B; Keating GM
    Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats.
    Azoubel MC; Menezes AM; Bezerra D; Oriá RB; Ribeiro RA; Brito GA
    Braz J Med Biol Res; 2007 Jan; 40(1):117-25. PubMed ID: 17225004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
    Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
    Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
    J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etoricoxib (Arcoxia)].
    Leclercq P; Malaise MG
    Rev Med Liege; 2004 May; 59(5):345-9. PubMed ID: 15270001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
    Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis.
    Bressan E; Tonussi CR
    Inflamm Res; 2008 Dec; 57(12):586-92. PubMed ID: 19109739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
    Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.